Siga Technologies price to free cash flow SIGA

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 8.6×; Jul 2026
7-year median: 8.4×
7-year range: 3.6× to 58.2×
Peer median: 11.4×

Siga Technologies' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Jul 2026, at 8.6×.

On the days it had one over the last 7 years, its median was 8.4×, from 3.6× in Mar 2026 to 58.2× in Dec 2023.

Price to free cash flow over time

median 8.4×

The dashed line is the 7-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.6×	3.6×	12.6×
2025	3.9×	3.6×	9.5×
2024	5.9×	5.5×	53.6×
2023	52.1×	7.5×	58.2×
2022	8.2×	7.4×	48.8×
2021	13.5×	6.6×	52.4×
2020	49.8×	47.7×	52.2×
2019	5.8×	5.1×	6.0×
2018	n/m a value too high to mean anything
2017	n/m a value too high to mean anything
2016	14.0×	1.1×	15.3×
2015	1.0×	0.7×	32.3×
2014	19.8×	0.9×	22.9×
2013	2.3×	2.1×	17.1×
2012	11.4×	5.3×	11.8×

Against its peers

Companies in Drug Manufacturers - General nearest Siga Technologies' size, closest first, today.

Company	Price to free cash flow
SIGASiga Technologies	n/m
NATRNatures Sunshine Products	11.8×
ARVNArvinas	n/m
PBYIPuma Biotechnology	13.8×
IRWDIronwood Pharmaceuticals	n/m
ZVRAZevra Therapeutics	17.9×
CRMDCorMedix	2.4×
LFVNLifevantage	11.0×
COLLCollegium Pharmaceutical	2.3×
SPROSpero Therapeutics	n/m
ABUSArbutus Biopharma	n/m
Peer median	11.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Siga Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.